Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Putative monooxygenase p33MONOX, abbreviated as KIAA1191, is a protein-coding gene that likely encodes an enzyme with NADPH-dependent oxidoreductase activity. It is located in the mitochondrion and may play a role in neuronal survival, differentiation, and axonal outgrowth, although its biological function is primarily predicted and not yet validated experimentally. The protein contains motifs similar to flavin monooxygenases but is considered "putative" due to limited functional characterization. There are numerous aliases, including p60MONOX, FLJ21022, and "brain-derived rescue factor p60MONOX," but no direct evidence currently supports its involvement in human disease or interaction with therapeutic drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Putative monooxygenase p33MONOX (KIAA1191).